The present study not only demonstrates that LMP7 may be a potential therapeutic target for prevention and treatment of obesity and metabolic disorders but also provides new insights into the mechanism underlying the pathophysiology of these disorders. This evidence concerns the gene PSMB8 and Other metabolic disease.